Correlation Between Citigroup and Medistim ASA

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Citigroup and Medistim ASA at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Citigroup and Medistim ASA into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Citigroup and Medistim ASA, you can compare the effects of market volatilities on Citigroup and Medistim ASA and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Citigroup with a short position of Medistim ASA. Check out your portfolio center. Please also check ongoing floating volatility patterns of Citigroup and Medistim ASA.

Diversification Opportunities for Citigroup and Medistim ASA

-0.84
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Citigroup and Medistim is -0.84. Overlapping area represents the amount of risk that can be diversified away by holding Citigroup and Medistim ASA in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Medistim ASA and Citigroup is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Citigroup are associated (or correlated) with Medistim ASA. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Medistim ASA has no effect on the direction of Citigroup i.e., Citigroup and Medistim ASA go up and down completely randomly.

Pair Corralation between Citigroup and Medistim ASA

Taking into account the 90-day investment horizon Citigroup is expected to generate 0.76 times more return on investment than Medistim ASA. However, Citigroup is 1.32 times less risky than Medistim ASA. It trades about 0.09 of its potential returns per unit of risk. Medistim ASA is currently generating about -0.04 per unit of risk. If you would invest  5,476  in Citigroup on September 1, 2024 and sell it today you would earn a total of  1,611  from holding Citigroup or generate 29.42% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Citigroup  vs.  Medistim ASA

 Performance 
       Timeline  
Citigroup 

Risk-Adjusted Performance

10 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Citigroup are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. In spite of rather unfluctuating fundamental indicators, Citigroup exhibited solid returns over the last few months and may actually be approaching a breakup point.
Medistim ASA 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Medistim ASA has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest conflicting performance, the Stock's essential indicators remain persistent and the latest mess on Wall Street may also be a sign of long-standing gains for the company institutional investors.

Citigroup and Medistim ASA Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Citigroup and Medistim ASA

The main advantage of trading using opposite Citigroup and Medistim ASA positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Citigroup position performs unexpectedly, Medistim ASA can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Medistim ASA will offset losses from the drop in Medistim ASA's long position.
The idea behind Citigroup and Medistim ASA pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.

Other Complementary Tools

Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Share Portfolio
Track or share privately all of your investments from the convenience of any device